Pharma-Bio Serv (PBSV) News Today $0.48 -0.02 (-4.00%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Scotiabank Initiates Coverage of BridgeBio Pharma (BBIO) with Sector Outperform RecommendationOctober 17, 2024 | msn.comBristol Myers, 2seventy bio halt enrollment in Abecma late-stage trialSeptember 25, 2024 | msn.comPBSV Makes Progress on ImprovementsSeptember 17, 2024 | msn.comPharma-Bio Serv Inc PBSVAugust 8, 2024 | morningstar.comSamsung Biologics joins the Pharmaceutical Supply Chain Initiative as Supplier PartnerAugust 6, 2024 | msn.comPharma-Bio Serv Inc.May 18, 2024 | wsj.comKörber Pharma and Siemens Take the Lead in ABI Research's MES Software for Pharmaceutical, Biotechnology, and Cell & Gene Manufacturing Competitive RankingMay 14, 2024 | msn.comBBIO Stock Earnings: BridgeBio Pharma Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | markets.businessinsider.comDeep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings)April 25, 2024 | markets.businessinsider.comEQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché LaboratóriosApril 25, 2024 | markets.businessinsider.comBiomarin Pharmaceutical earnings preview: what Wall Street is expectingApril 23, 2024 | markets.businessinsider.comBuy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market ExpectationsApril 16, 2024 | markets.businessinsider.comSanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.com's Supplier Pre-assessment ProgramApril 9, 2024 | tmcnet.comLooking Into Biomarin Pharmaceutical's Recent Short InterestApril 3, 2024 | benzinga.comPBSV Releases Quarterly ResultsMarch 19, 2024 | finance.yahoo.comPharma-Bio Serv reports Q1 resultsMarch 19, 2024 | seekingalpha.comBuy Rating Affirmed for BridgeBio Pharma Amidst Strategic Bayer Collaboration and Promising Financial OutlookMarch 4, 2024 | markets.businessinsider.comMaintaining Hold on BridgeBio Pharma Amidst Bayer Partnership and Market UncertaintiesMarch 4, 2024 | markets.businessinsider.comBioMarin Pharmaceutical Gets DOJ Subpoena for Documents Related to Vimizim, Naglazyme -- UpdateFebruary 26, 2024 | marketwatch.comStrong Voxzogo Performance Underpins Buy Rating for BioMarin PharmaceuticalFebruary 23, 2024 | markets.businessinsider.comPBSV Expands Margins and MarketsJanuary 30, 2024 | finance.yahoo.comJubilant Pharma Plans Stake Sale in Sofie Biosciences Amid Merger DealJanuary 28, 2024 | msn.comOptimistic Outlook: Buy Rating for BridgeBio Pharma with Promising Treatment Launches and Strategic Growth DriversJanuary 9, 2024 | markets.businessinsider.comBridgeBio Pharma's Robust Pipeline Could Benefit From A PartnerJanuary 8, 2024 | seekingalpha.comPBSV Reward Shareholders with High YieldJanuary 3, 2024 | finance.yahoo.comPharma-Bio Serv Inc.: Pharma-Bio Serv Announces Special DividendDecember 21, 2023 | finanznachrichten.deAbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?December 8, 2023 | msn.comBioMarin Pharma Reaches Agreement On Reimbursement Amount For ROCTAVIAN In GermanyNovember 28, 2023 | markets.businessinsider.comPromising Future for BridgeBio Pharma: Lebovitz’s Buy Rating Backed by Potential Blockbusters and Pipeline AssetsNovember 7, 2023 | markets.businessinsider.comBridgeBio Pharma Receives Buy Rating Amid Promising Drug Pipeline Developments and Strong Financial PositionNovember 6, 2023 | markets.businessinsider.comPBSV Boosts Margins and Expands MarketsSeptember 15, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023September 14, 2023 | finance.yahoo.comAnalysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN) and Phibro Animal Health (PAHC)August 31, 2023 | markets.businessinsider.comPharma-Bio Serv IncJuly 28, 2023 | thestreet.comBridgeBio Pharma: Positive ATTR-CM Treatment Data Leads To Other 2023 CatalystsJuly 17, 2023 | msn.comBridgeBio Pharma Shares Rise 14% on Expected Results from Heart-Disease StudyJuly 15, 2023 | marketwatch.comStocks to Watch: BridgeBio Pharma, Universal Security Instruments, BYND Cannasoft EnterprisesJuly 15, 2023 | marketwatch.comPearl Bio Secures Breakthrough IP for Multi-Functionalized BiologicsJune 20, 2023 | technews.tmcnet.comPBSV: A Consistent Performer with Impressive DividendJune 15, 2023 | finance.yahoo.comPharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023June 14, 2023 | finance.yahoo.comTBPMF - Tetra Bio-Pharma Inc.June 13, 2023 | ca.finance.yahoo.comPBSV - Pharma-Bio Serv, Inc.June 10, 2023 | finance.yahoo.comAvid Bioservices Bolsters Manufacturing Capabilities And Generates High-Demand ServicesMay 20, 2023 | msn.comBridgeBio Pharma to Present Updated Data from itsMay 15, 2023 | tmcnet.comBio Pharma Buffer Market Research | 2023-2030May 10, 2023 | marketwatch.comGlobal "Bio Pharma Logistics Market" 2023 Research Report | Enhanced Growth Size, Estimates and Regional Outlook by 2030 | Research Reports WorldMay 9, 2023 | marketwatch.comHere's what Wall Street expects from Biomarin Pharmaceutical's earningsApril 25, 2023 | markets.businessinsider.comPharma-Bio Serv Stock (OTC:PBSV), Quotes and News SummaryApril 20, 2023 | benzinga.comBio Pharma Buffer Market 2023 Size and Forecast to 2031April 8, 2023 | marketwatch.comPBSV: A Steady Performer with Upside PotentialMarch 20, 2023 | finance.yahoo.com Get Pharma-Bio Serv News Delivered to You Automatically Sign up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin PBSV Media Mentions By Week PBSV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PBSV News Sentiment▼0.000.54▲Average Business Services News Sentiment PBSV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PBSV Articles This Week▼00▲PBSV Articles Average Week Get Pharma-Bio Serv News Delivered to You Automatically Sign up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies XBP News Today STCB News Today ISDR News Today FPAY News Today SCOR News Today SJ News Today CDTG News Today INUV News Today BTCM News Today GEVI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PBSV) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharma-Bio Serv, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharma-Bio Serv With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
